Literature DB >> 26791625

Tranexamic acid in life-threatening military injury and the associated risk of infective complications.

C J Lewis1,2, P Li3,4, L Stewart3,4, A C Weintrob3,4,5, M L Carson3,4, C K Murray6, D R Tribble3, J D Ross1.   

Abstract

BACKGROUND: Tranexamic acid (TXA) has been shown to reduce mortality from severe haemorrhage. Although recent data suggest that TXA has anti-inflammatory properties, few analyses have investigated the impact of TXA on infectious complications in injured patients. The aim was to examine the association between TXA administration and infection risk among injured military personnel.
METHODS: Patients who received TXA were matched by Injury Severity Score with patients who did not receive TXA. Conditional logistic regression was used to examine risk factors associated with infections within 30 days. A Cox proportional analysis evaluated risk factors in a time-to-first-infection model.
RESULTS: A total of 335 TXA recipients were matched with 626 patients who did not receive TXA. A greater proportion of TXA recipients had an infection compared with the comparator group (P < 0·001). Univariable analysis estimated an unadjusted odds ratio (OR) of 2·47 (95 per cent c.i. 1·81 to 3·36) for the association between TXA and infection risk; however, TXA administration was not significant in multivariable analysis (OR 1·27, 0·85 to 1·91). Blast injuries, intensive care unit (ICU) admission, and receipt of 10 units or more of blood within 24 h after injury were independently associated with infection risk. The Cox proportional model confirmed the association with ICU admission and blood transfusion. Traumatic amputations were also significantly associated with a reduced time to first infection.
CONCLUSION: In life-threatening military injuries matched for injury severity, TXA recipients did not have a higher risk of having infections nor was the time to develop infections shorter than in non-recipients. Extent of blood loss, blast injuries, extremity amputations and ICU stay were associated with infection.
© 2016 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26791625      PMCID: PMC4760875          DOI: 10.1002/bjs.10055

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  25 in total

1.  Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study.

Authors:  Jonathan J Morrison; Joseph J Dubose; Todd E Rasmussen; Mark J Midwinter
Journal:  Arch Surg       Date:  2011-10-17

Review 2.  The injury severity score--importance and uses.

Authors:  S Linn
Journal:  Ann Epidemiol       Date:  1995-11       Impact factor: 3.797

3.  A comparative study of the immune modulating properties of antifibrinolytics in cardiac surgery.

Authors:  A F L Later; E F Bruggemans; F P H T M Romijn; J van Pelt; R J M Klautz
Journal:  Cytokine       Date:  2012-11-24       Impact factor: 3.861

4.  Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial.

Authors:  Mehmet B Sentürk; Yusuf Cakmak; Gazi Yildiz; Pınar Yildiz
Journal:  Arch Gynecol Obstet       Date:  2012-11-11       Impact factor: 2.344

5.  Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization.

Authors:  Eric W G Weber; Robert Slappendel; Martin H Prins; Dick B van der Schaaf; Marcel E Durieux; Danja Strümper
Journal:  Anesth Analg       Date:  2005-05       Impact factor: 5.108

6.  The nature and extent of war injuries sustained by combat specialty personnel killed and wounded in Afghanistan and Iraq, 2003-2011.

Authors:  Andrew J Schoenfeld; John C Dunn; Julia O Bader; Philip J Belmont
Journal:  J Trauma Acute Care Surg       Date:  2013-08       Impact factor: 3.313

Review 7.  Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations.

Authors:  David S Kauvar; Rolf Lefering; Charles E Wade
Journal:  J Trauma       Date:  2006-06

8.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.

Authors:  Haleema Shakur; Ian Roberts; Raúl Bautista; José Caballero; Tim Coats; Yashbir Dewan; Hesham El-Sayed; Tamar Gogichaishvili; Sanjay Gupta; Jorge Herrera; Beverley Hunt; Pius Iribhogbe; Mario Izurieta; Hussein Khamis; Edward Komolafe; María-Acelia Marrero; Jorge Mejía-Mantilla; Jaime Miranda; Carlos Morales; Oluwole Olaomi; Fatos Olldashi; Pablo Perel; Richard Peto; P V Ramana; R R Ravi; Surakrant Yutthakasemsunt
Journal:  Lancet       Date:  2010-06-14       Impact factor: 79.321

9.  Adherence to published antimicrobial prophylaxis guidelines for wounded service members in the ongoing conflicts in Southwest Asia.

Authors:  Bradley A Lloyd; Amy C Weintrob; Mary K Hinkle; Gerald R Fortuna; Clinton K Murray; William Bradley; Eugene V Millar; Faraz Shaikh; Kristen Vanderzant; Stacie Gregg; Gina Lloyd; Julie Stevens; M Leigh Carson; Deepak Aggarwal; David R Tribble
Journal:  Mil Med       Date:  2014-03       Impact factor: 1.437

10.  Pharmacokinetics and bioavailability of tranexamic acid.

Authors:  A Pilbrant; M Schannong; J Vessman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more
  6 in total

Review 1.  Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?

Authors:  Hunter B Moore; Robert D Winfield; Mayuki Aibiki; Matthew D Neal
Journal:  Shock       Date:  2017-08       Impact factor: 3.454

2.  IDCRP Trauma-Related Infection Research.

Authors:  David R Tribble
Journal:  Mil Med       Date:  2022-05-04       Impact factor: 1.563

3.  Early Infections Complicating the Care of Combat Casualties from Iraq and Afghanistan.

Authors:  Amy C Weintrob; Clinton K Murray; Jiahong Xu; Margot Krauss; William Bradley; Tyler E Warkentien; Bradley A Lloyd; David R Tribble
Journal:  Surg Infect (Larchmt)       Date:  2018-01-19       Impact factor: 2.150

4.  Mortality and Thrombosis in Injured Adults Receiving Tranexamic Acid in the Post-CRASH-2 Era.

Authors:  Simranjeet Benipal; John-Lloyd Santamarina; Linda Vo; Daniel K Nishijima
Journal:  West J Emerg Med       Date:  2019-04-26

5.  Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury: A Systematic Review and Meta-analysis.

Authors:  Vivien Karl; Sophie Thorn; Tim Mathes; Simone Hess; Marc Maegele
Journal:  JAMA Netw Open       Date:  2022-03-01

6.  Introduction of a standardised protocol, including systematic use of tranexamic acid, for management of severe adult trauma patients in a low-resource setting: the MSF experience from Port-au-Prince, Haiti.

Authors:  Alessandro Jachetti; Rose Berly Massénat; Nathalie Edema; Sophia C Woolley; Guido Benedetti; Rafael Van Den Bergh; Miguel Trelles
Journal:  BMC Emerg Med       Date:  2019-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.